I'm Liking What I'm Seeing from ENTB
Nice week and strong performance from this innovative biotech company. 3.00 definitely looks doable in the short term, especially if the company can stay focused on its R&D and its product services. It looks like ENTB's solid now in the peer review field as well.
The stock definitely looks like it could support concerted upward movement over the immediate future. In fact, 3.00 may be too conservative. I'm hoping to see its best 52-week high not too far down the road. Time to take a stronger position, I think. At minimum, I'm betting on a nice margin increase this week and next
I've been studying ENTB's revenue projections and cash flows (from the materials I could get online) and I think they've aligned their revenue projections with what they can reasonably expect over the next quarter or so. It definitely looks solid, which gives me the feeling that they're going to make a strong move upwards fairly soon. Certainly, given how they've performed this week (maintaining their increases against end-of-day activity), I think they're demonstrating real staying power nowadays.
Biotechs are always an area in which the particular biotech company has to do a great job of explaining – IN LAYMAN’S TERMS – just what their products are going to do and how successfully the company will perform in the markets. If they can do that, as ENTB is currently doing, they’ll THRIVE and not just survive. It’s good to see the company take an aggressive position in explaining what it’s doing, how it’s doing and how it’s going to go forward in the future. It helps convince investors that it’s got the juice, so to speak, and that’s a good thing!
Nice week and strong performance from this innovative biotech company. 3.00 definitely looks doable in the short term, especially if the company can stay focused on its R&D and its product services. It looks like ENTB's solid now in the peer review field as well.
The stock definitely looks like it could support concerted upward movement over the immediate future. In fact, 3.00 may be too conservative. I'm hoping to see its best 52-week high not too far down the road. Time to take a stronger position, I think. At minimum, I'm betting on a nice margin increase this week and next
I've been studying ENTB's revenue projections and cash flows (from the materials I could get online) and I think they've aligned their revenue projections with what they can reasonably expect over the next quarter or so. It definitely looks solid, which gives me the feeling that they're going to make a strong move upwards fairly soon. Certainly, given how they've performed this week (maintaining their increases against end-of-day activity), I think they're demonstrating real staying power nowadays.
Biotechs are always an area in which the particular biotech company has to do a great job of explaining – IN LAYMAN’S TERMS – just what their products are going to do and how successfully the company will perform in the markets. If they can do that, as ENTB is currently doing, they’ll THRIVE and not just survive. It’s good to see the company take an aggressive position in explaining what it’s doing, how it’s doing and how it’s going to go forward in the future. It helps convince investors that it’s got the juice, so to speak, and that’s a good thing!
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
